Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy

BACKGROUND: The advanced lung cancer inflammation index (ALI) has been reported to predict the overall survival in patients with advanced non-small cell lung cancer (NSCLC). However, no previous studies have examined the prognostic significance of ALI in metastatic NSCLC treated with first line chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Chantharakhit, Chaichana, Sujaritvanichpong, Nantapa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325112/
https://www.ncbi.nlm.nih.gov/pubmed/33906307
http://dx.doi.org/10.31557/APJCP.2021.22.4.1149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325112/
https://www.ncbi.nlm.nih.gov/pubmed/33906307
http://dx.doi.org/10.31557/APJCP.2021.22.4.1149

Ejemplares similares